Restricted intake of sulfur-containing amino acids reversed the hepatic injury induced by excess Desulfovibrio through gut–liver axis

References

• Tilg H, Adolph TE, Trauner M. Gut-liver axis: Pathophysiological concepts and clinical implications. Cell Metab. 2022;34(11):1700–28. doi:10.1016/j.cmet.2022.09.017.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut–liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15(7):397–411. doi:10.1038/s41575-018-0011-z.
   PubMed Web of Science ®Google Scholar
• Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72(3):558–577. doi:10.1016/j.jhep.2019.10.003.
   PubMed Web of Science ®Google Scholar
• Wahlström A, Sayin S, Marschall I, H -U, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005.
   PubMed Web of Science ®Google Scholar
• Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2023;21(4):236–247. doi:10.1038/s41579-022-00805-x.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR, Kaneider NC. Pathways of liver injury in alcoholic liver disease. J Hepatol. 2011;55(5):1159–1161. doi:10.1016/j.jhep.2011.05.015.
   PubMed Web of Science ®Google Scholar
• Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20(1):40–54. doi:10.1038/s41577-019-0198-4.
   PubMed Web of Science ®Google Scholar
• Trebicka J, Macnaughtan J, Schnabl B, Shawcross DL, Bajaj JS. The microbiota in cirrhosis and its role in hepatic decompensation. J Hepatol. 2021;75(1):S67–S81. doi:10.1016/j.jhep.2020.11.013.
   PubMedGoogle Scholar
• Carpino G, Del Ben M, Pastori D, Carnevale R, Baratta F, Overi D, Francis H, Cardinale V, Onori P, Safarikia S, et al. Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD. Hepatology. 2020;72(2):470–485. doi:10.1002/hep.31056.
   PubMed Web of Science ®Google Scholar
• Hoyles L, Fernández-Real J-M, Federici M, Serino M, Abbott J, Charpentier J, Heymes C, Luque JL, Anthony E, Barton RH, et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med. 2018;24(7):1070–1080. doi:10.1038/s41591-018-0061-3.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. doi:10.1038/s41579-020-0433-9.
   PubMed Web of Science ®Google Scholar
• Cani PD, Van Hul M. Mediterranean diet, gut microbiota and health: when age and calories do not add up! Gut. 2020;69(7):1167–1168. doi:10.1136/gutjnl-2020-320781.
   PubMed Web of Science ®Google Scholar
• Bárcena C, Quirós PM, Durand S, Mayoral P, Rodríguez F, Caravia XM, Mariño G, Garabaya C, Fernández-García MT, Kroemer G, et al. Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism. Cell Rep. 2018;24(9):2392–2403. doi:10.1016/j.celrep.2018.07.089.
   PubMed Web of Science ®Google Scholar
• Green CL, Lamming DW, Fontana L. Molecular mechanisms of dietary restriction promoting health and longevity. Nat Rev Mol Cell Biol. 2022;23(1):56–73. doi:10.1038/s41580-021-00411-4.
   PubMed Web of Science ®Google Scholar
• Miller RA, Buehner G, Chang Y, Harper JM, Sigler R, Smith‐Wheelock M. Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell. 2005;4(3):119–125. doi:10.1111/j.1474-9726.2005.00152.x.
   PubMed Web of Science ®Google Scholar
• Ren B, Wang L, Mulati A, Liu Y, Liu Z, Liu X. Methionine Restriction Improves Gut Barrier Function by Reshaping Diurnal Rhythms of Inflammation-Related Microbes in Aged Mice. Front Nutr. 2021;8:746592. doi:10.3389/fnut.2021.746592.
   PubMed Web of Science ®Google Scholar
• National Research Council (US) Subcommittee on Laboratory Animal Nutrition. Nutrient requirements of laboratory animals. Fourth Revised ed. Washington (DC): National Academies Press (US); 1995. doi:10.17226/4758.
   Google Scholar
• Pellizzon MA, Ricci MR. The common use of improper control diets in diet-induced metabolic disease research confounds data interpretation: the fiber factor. Nutr Metab (Lond). 2018;15(3). doi:10.1186/s12986-018-0243-5.
   Google Scholar
• Daniel N, Rossi Perazza L, Varin TV, Trottier J, Marcotte B, St-Pierre P, Barbier O, Chassaing B, Marette A. Dietary fat and low fiber in purified diets differently impact the gut-liver axis to promote obesity-linked metabolic impairments. Am J Physiol Gastrointest Liver Physiol. 2021;320(6):G1014–G1033. doi:10.1152/ajpgi.00028.2021.
   PubMed Web of Science ®Google Scholar
• Hou Y, Wei W, Guan X, Liu Y, Bian G, He D, Fan Q, Cai X, Zhang Y, Wang G, et al. A diet-microbial metabolism feedforward loop modulates intestinal stem cell renewal in the stressed gut. Nat Commun. 2021;12(1):271. doi:10.1038/s41467-020-20673-4.
   PubMed Web of Science ®Google Scholar
• Goto H, Takemura N, Ogasawara T, Sasajima N, Watanabe J, Ito H, Morita T, Sonoyama K. Effects of Fructo-Oligosaccharide on DSS-Induced colitis differ in mice fed nonpurified and purified diets. The Journal Of Nutrition. 2010;140(12):2121–2127. doi:10.3945/jn.110.125948.
   PubMed Web of Science ®Google Scholar
• Boussenna A, Goncalves-Mendes N, Joubert-Zakeyh J, Pereira B, Fraisse D, Vasson M-P, Texier O, Felgines C. Impact of basal diet on dextran sodium sulphate (DSS)-induced colitis in rats. Eur J Nutr. 2015;54(8):1217–1227. doi:10.1007/s00394-014-0800-2.
   PubMed Web of Science ®Google Scholar
• Koleva P, Ketabi A, Valcheva R, Ganzle MG, Dieleman LA. Chemically defined diet alters the protective properties of fructo-oligosaccharides and isomalto-oligosaccharides in HLA-B27 transgenic rats. PLoS One. 2014;9(11):e111717. doi:10.1371/journal.pone.0111717.
   PubMed Web of Science ®Google Scholar
• Miles JP, Zou J, Kumar M-V, Pellizzon M, Ulman E, Ricci M, Gewirtz AT, Chassaing B. Supplementation of low- and high-fat diets with fermentable fiber exacerbates severity of DSS-induced acute colitis. Inflamm Bowel Dis. 2017;23(7):1133–1143. doi:10.1097/MIB.0000000000001155.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Blazquez R, Alcalá M, Fernández-Alfonso MS, Villa-Valverde P, Viana M, Gil-Ortega M, Somoza B. Relevance of control diet choice in metabolic studies: impact in glucose homeostasis and vascular function. Sci Rep. 2020;10(1):2902. doi:10.1038/s41598-020-59674-0.
   PubMed Web of Science ®Google Scholar
• Javdan B, Lopez JG, Chankhamjon P, Lee YCJ, Hull R, Wu Q, Wang X, Chatterjee S, Donia MS. Personalized mapping of drug metabolism by the human gut microbiome. Cell. 2020;181(7):1661–1679 e1622. doi:10.1016/j.cell.2020.05.001.
   PubMed Web of Science ®Google Scholar
• Xiao L, Feng Q, Liang S, Sonne SB, Xia Z, Qiu X, Li X, Long H, Zhang J, Zhang D, et al. A catalog of the mouse gut metagenome. Nat Biotechnol. 2015;33(10):1103–1108. doi:10.1038/nbt.3353.
   PubMed Web of Science ®Google Scholar
• Shalon D, Culver RN, Grembi JA, Folz J, Treit PV, Shi H, Rosenberger FA, Dethlefsen L, Meng X, Yaffe E, et al. Profiling the human intestinal environment under physiological conditions. Nature. 2023;617(7961):581–591. doi:10.1038/s41586-023-05989-7.
   PubMed Web of Science ®Google Scholar
• Kastl AJ Jr., Terry NA, Wu GD, Albenberg LG. The structure and function of the human small intestinal microbiota: current understanding and future directions. Cell Mol Gastroenterol Hepatol. 2020;9(1):33–45. doi:10.1016/j.jcmgh.2019.07.006.
   PubMed Web of Science ®Google Scholar
• Xie G, Wang X, Liu P, Wei R, Chen W, Rajani C, Hernandez BY, Alegado R, Dong B, Li D, et al. Distinctly altered gut microbiota in the progression of liver disease. Oncotarget. 2016;7(15):19355–19366. doi:10.18632/oncotarget.8466.
   PubMed Web of Science ®Google Scholar
• Fuchs CD, Trauner M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat Rev Gastro Hepat. 2022;19(7):432–450. doi:10.1038/s41575-021-00566-7.
   PubMed Web of Science ®Google Scholar
• Zhang X, Coker OO, Chu ES, Fu K, Lau HCH, Wang Y-X, Chan AWH, Wei H, Yang X, Sung JJY, et al. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut. 2021;70(4):761–774. doi:10.1136/gutjnl-2019-319664.
   PubMed Web of Science ®Google Scholar
• Munteanu C, Turnea MA, Rotariu M. Hydrogen Sulfide: An emerging regulator of oxidative stress and cellular homeostasis—a comprehensive one-year review. Antioxid (Basel). 2023;12(9):1737. doi:10.3390/antiox12091737.
   PubMedGoogle Scholar
• Wu B, Liu F, Fang W, Yang T, Chen G-H, He Z, Wang S. Microbial sulfur metabolism and environmental implications. Sci Total Environ. 2021;778:146085. doi:10.1016/j.scitotenv.2021.146085.
   PubMed Web of Science ®Google Scholar
• Feng J, Jiang W, Cheng X, Zou B, Varley AW, Liu T, Qian G, Zeng W, Tang J, Zhao Q, et al. A host lipase prevents lipopolysaccharide-induced foam cell formation. iScience. 2021;24(9):103004. doi:10.1016/j.isci.2021.103004.
   PubMed Web of Science ®Google Scholar
• Han YH, Onufer EJ, Huang L-H, Sprung RW, Davidson WS, Czepielewski RS, Wohltmann M, Sorci-Thomas MG, Warner BW, Randolph GJ, et al. Enterically derived high-density lipoprotein restrains liver injury through the portal vein. Science. 2021;373(6553). doi:10.1126/science.abe6729.
   Web of Science ®Google Scholar
• Song Z, Cai Y, Lao X, Wang X, Lin X, Cui Y, Kalavagunta PK, Liao J, Jin L, Shang J, et al. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome. Microbiome. 2019;7(1). doi:10.1186/s40168-019-0628-3.
   Google Scholar
• Kitada M, Ogura Y, Monno I, Koya D. The impact of dietary protein intake on longevity and metabolic health. EBioMedicine. 2019;43:632–640. doi:10.1016/j.ebiom.2019.04.005.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi:10.1038/nature05414.
   PubMed Web of Science ®Google Scholar
• Cai J, Sun L, Gonzalez FJ. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe. 2022;30(3):289–300. doi:10.1016/j.chom.2022.02.004.
   PubMed Web of Science ®Google Scholar
• Kim KH, Park D, Jia B, Baek JH, Hahn Y, Jeon CO. Identification and characterization of major bile Acid 7α-Dehydroxylating bacteria in the human gut. mSystems. 2022;7(4):e0045522. doi:10.1128/msystems.00455-22.
   PubMed Web of Science ®Google Scholar
• Claus SP, Tsang TM, Wang Y, Cloarec O, Skordi E, Martin F-P, Rezzi S, Ross A, Kochhar S, Holmes E, et al. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol. 2008;4(1):219. doi:10.1038/msb.2008.56.
   PubMedGoogle Scholar
• Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, Nicholson JK, Holmes E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A. 2011;108 Suppl 1(supplement_1):4523–4530. doi:10.1073/pnas.1006734107.
   PubMedGoogle Scholar
• Chen SN, Tan Y, Xiao X-C, Li Q, Wu Q, Peng Y-Y, Ren J, Dong M-L. Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis. Acta Pharmacol Sin. 2021;42(10):1610–1619. doi:10.1038/s41401-020-00597-x.
   PubMed Web of Science ®Google Scholar
• Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–1772. doi:10.2337/db06-1491.
   PubMed Web of Science ®Google Scholar
• Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in High-Fat Diet–Induced obesity and diabetes in mice. Diabetes. 2008;57(6):1470–1481. doi:10.2337/db07-1403.
   PubMed Web of Science ®Google Scholar
• Sookoian S, Salatino A, Castaño GO, Landa MS, Fijalkowky C, Garaycoechea M, Pirola CJ. Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease. Gut. 2020;69(8):1483–1491. doi:10.1136/gutjnl-2019-318811.
   PubMed Web of Science ®Google Scholar
• Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol. 1991;12(2):162–169. doi:10.1016/0168-8278(91)90933-3.
   PubMed Web of Science ®Google Scholar
• Munoz L, Borrero M-J, Úbeda M, Conde E, Del Campo R, Rodríguez‐Serrano M, Lario M, Sánchez‐Díaz A-M, Pastor O, Díaz D, et al. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats with Cirrhosis. Hepatology. 2019;70(3):925–938. doi:10.1002/hep.30349.
   PubMed Web of Science ®Google Scholar
• Sorribas M, Jakob MO, Yilmaz B, Li H, Stutz D, Noser Y, de Gottardi A, Moghadamrad S, Hassan M, Albillos A, et al. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis. J Hepatol. 2019;71(6):1126–1140. doi:10.1016/j.jhep.2019.06.017.
   PubMed Web of Science ®Google Scholar
• Gandhi CR. Pro- and Anti-fibrogenic Functions of Gram-Negative Bacterial lipopolysaccharide in the liver. Front Med (Lausanne). 2020;7:130. doi:10.3389/fmed.2020.00130.
   PubMed Web of Science ®Google Scholar
• Xu MQ, Cen M, Shen Y, Zhu Y, Cheng F, Tang L, Hu W, Dai N. Deoxycholic Acid-Induced gut dysbiosis disrupts bile acid enterohepatic circulation and promotes intestinal Inflammation. Dig Dis Sci. 2021;66(2):568–576. doi:10.1007/s10620-020-06208-3.
   PubMed Web of Science ®Google Scholar
• Liu L, Dong W, Wang S, Zhang Y, Liu T, Xie R, Wang B, Cao H. Deoxycholic acid disrupts the intestinal mucosal barrier and promotes intestinal tumorigenesis. Food Funct. 2018;9(11):5588–5597. doi:10.1039/C8FO01143E.
   PubMed Web of Science ®Google Scholar
• Jia W, Xie G, Jia W. Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111–128. doi:10.1038/nrgastro.2017.119.
   PubMed Web of Science ®Google Scholar
• Gadaleta RM, Garcia-Irigoyen O, Moschetta A. Bile acids and colon cancer: Is FXR the solution of the conundrum? Mol Aspects Med. 2017;56:66–74. doi:10.1016/j.mam.2017.04.002.
   PubMed Web of Science ®Google Scholar
• Payne CM, Bernstein C, Dvorak K, Bernstein H. Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol. 2008;1:19–47. doi:10.2147/CEG.S4343.
   PubMedGoogle Scholar
• Woolbright BL, McGill MR, Yan H, Jaeschke H. Bile Acid-Induced Toxicity in Heparg cells recapitulates the response in primary human hepatocytes. Basic Clin Pharmacol Toxicol. 2016;118(2):160–167. doi:10.1111/bcpt.12449.
   PubMed Web of Science ®Google Scholar
• Woolbright BL, Dorko K, Antoine DJ, Clarke JI, Gholami P, Li F, Kumer SC, Schmitt TM, Forster J, Fan F, et al. Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis. Toxicol Appl Pharmacol. 2015;283(3):168–177. doi:10.1016/j.taap.2015.01.015.
   PubMed Web of Science ®Google Scholar
• Song P, Zhang Y, Klaassen CD. Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicity in mice. Toxicol Sci. 2011;123(2):359–367. doi:10.1093/toxsci/kfr177.
   PubMed Web of Science ®Google Scholar
• Miyake JH, Wang SL, Davis RA. Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7α-hydroxylase. J Biol Chem. 2000;275(29):21805–21808. doi:10.1074/jbc.C000275200.
   PubMed Web of Science ®Google Scholar
• Sato K, Hall C, Glaser S, Francis H, Meng F, Alpini G. Pathogenesis of Kupffer Cells in Cholestatic Liver Injury. Am J Pathol. 2016;186(9):2238–2247. doi:10.1016/j.ajpath.2016.06.003.
   PubMed Web of Science ®Google Scholar
• Allen K, Jaeschke H, Copple BL. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol. 2011;178(1):175–186. doi:10.1016/j.ajpath.2010.11.026.
   PubMed Web of Science ®Google Scholar
• Rahman AH, Aloman C. Dendritic cells and liver fibrosis. Biochim Biophys Acta. 2013;1832(7):998–1004. doi:10.1016/j.bbadis.2013.01.005.
   PubMed Web of Science ®Google Scholar
• Carambia A, Freund B, Schwinge D, Heine M, Laschtowitz A, Huber S, Wraith DC, Korn T, Schramm C, Lohse AW, et al. TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells. J Hepatol. 2014;61(3):594–599. doi:10.1016/j.jhep.2014.04.027.
   PubMed Web of Science ®Google Scholar
• Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97–101. doi:10.1038/nature12347.
   PubMed Web of Science ®Google Scholar
• Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88(1):125–172. doi:10.1152/physrev.00013.2007.
   PubMed Web of Science ®Google Scholar
• Allocati N, Masulli M, Di Ilio C, Federici L. Glutathione transferases: substrates, inhibitors and pro-drugs in cancer and neurodegenerative diseases. Oncogenesis. 2018;7(8). doi:10.1038/s41389-017-0025-3.
   PubMedGoogle Scholar
• Dasari S, Ganjayi MS, Yellanurkonda P, Basha S, Meriga B. Role of glutathione S-transferases in detoxification of a polycyclic aromatic hydrocarbon, methylcholanthrene. Chem Biol Interact. 2018;294:81–90. doi:10.1016/j.cbi.2018.08.023.
   PubMed Web of Science ®Google Scholar
• Li G, Liu H, Yu Y, Wang Q, Yang C, Yan Y, Wang F, Mao Y. Desulfovibrio desulfuricans and its derived metabolites confer resistance to FOLFOX through METTL3. eBiomedicine. 2024;102:105041. doi:10.1016/j.ebiom.2024.105041.
   PubMed Web of Science ®Google Scholar
• Lu XY, Shi X-J, Hu A, Wang J-Q, Ding Y, Jiang W, Sun M, Zhao X, Luo J, Qi W, et al. Feeding induces cholesterol biosynthesis via the mTORC1–USP20–HMGCR axis. Nature. 2020;588(7838):479–484. doi:10.1038/s41586-020-2928-y.
   PubMed Web of Science ®Google Scholar
• Lu G, Zhang Y, Ren Y, Shi J-S, Xu Z-H, Geng Y. Diversity and comparison of intestinal desulfovibrio in patients with liver cirrhosis and healthy people. Microorganisms. 2023;11(2):276. doi:10.3390/microorganisms11020276.
   PubMed Web of Science ®Google Scholar
• Pimentel Jason D, Chan Raymond C. Desulfovibrio fairfieldensis bacteremia associated with choledocholithiasis and endoscopic retrograde cholangiopancreatography. J Clin Microbiol. 2007;45(8):2747–2750. doi:10.1128/JCM.00969-07.
   PubMed Web of Science ®Google Scholar
• Nie Y, Xie X-Q, Zhou L, Guan Q, Ren Y, Mao Y, Shi J-S, Xu Z-H, Geng Y. Desulfovibrio fairfieldensis-derived outer membrane vesicles damage epithelial barrier and induce inflammation and pyroptosis in macrophages. Cells. 2022;12(1):89. doi:10.3390/cells12010089.
   PubMed Web of Science ®Google Scholar